{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,14]],"date-time":"2025-05-14T06:07:23Z","timestamp":1747202843834,"version":"3.40.5"},"reference-count":60,"publisher":"Archives of Endocrinology and Metabolism","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,4,27]]},"DOI":"10.20945\/2359-3997000000358","type":"journal-article","created":{"date-parts":[[2021,5,11]],"date-time":"2021-05-11T15:40:03Z","timestamp":1620747603000},"source":"Crossref","is-referenced-by-count":1,"title":["Apoplexy in sporadic pituitary adenomas: a single referral center experience and AIP mutation analysis"],"prefix":"10.20945","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3178-957X","authenticated-orcid":false,"given":"Christhiane","family":"Fialho","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2379-6596","authenticated-orcid":false,"given":"Monique \u00c1lvares","family":"Barbosa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2299-4814","authenticated-orcid":false,"given":"Carlos Henrique Azeredo","family":"Lima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2692-4960","authenticated-orcid":false,"given":"Luiz Eduardo Armondi","family":"Wildemberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9250-3558","authenticated-orcid":false,"given":"M\u00f4nica R.","family":"Gadelha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1339-3192","authenticated-orcid":false,"given":"Leandro","family":"Kasuki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"8510","reference":[{"issue":"2","key":"key20210511112242_B1","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1177\/0885066607312992","article-title":"Pituitary tumor apoplexy: a review","volume":"23","author":"Nawar","year":"2008","unstructured":"1. Nawar RN, AbdelMannan D, Selman WR, Arafah BM. Pituitary tumor apoplexy: a review. J Intensive Care Med. 2008;23(2):75-90.","journal-title":"J Intensive Care Med"},{"issue":"1","key":"key20210511112242_B2","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1111\/j.1365-2265.2010.03913.x","article-title":"UK guidelines for the management of pituitary apoplexy","volume":"74","author":"Rajasekaran","year":"2011","unstructured":"2. Rajasekaran S, Vanderpump M, Baldeweg S, Drake W, Reddy N, Lanyon M, et al. UK guidelines for the management of pituitary apoplexy. Clin Endocrinol. 2011;74(1):9-20.","journal-title":"Clin Endocrinol"},{"issue":"2","key":"key20210511112242_B3","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1046\/j.1365-2265.1999.00754.x","article-title":"Classical pituitary apoplexy: clinical features, management and outcome","volume":"51","author":"Randeva","year":"1999","unstructured":"3. Randeva HS, Schoebel J, Byrne J, Esiri M, Adams CB, Wass JA. Classical pituitary apoplexy: clinical features, management and outcome. Clin Endocrinol (Oxf). 1999;51(2):181-8.","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"2","key":"key20210511112242_B4","doi-asserted-by":"crossref","first-page":"187","DOI":"10.3171\/jns.1981.55.2.0187","article-title":"Pituitary apoplexy: its incidence and clinical significance","volume":"55","author":"Wakai","year":"1981","unstructured":"4. Wakai S, Fukushima T, Teramoto A, Sano K. Pituitary apoplexy: its incidence and clinical significance. J Neurosurg. 1981;55(2):187-93.","journal-title":"J Neurosurg"},{"issue":"2","key":"key20210511112242_B5","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1007\/s11910-007-0004-8","article-title":"Thunderclap headache: an approach to a neurologic emergency","volume":"7","author":"Matharu","year":"2007","unstructured":"5. Matharu MS, Schwedt TJ, Dodick DW. Thunderclap headache: an approach to a neurologic emergency. Curr Neurol Neurosci Rep. 2007;7(2):101-9.","journal-title":"Curr Neurol Neurosci Rep"},{"issue":"3","key":"key20210511112242_B6","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1007\/s11102-005-1050-3","article-title":"Pituitary apoplexy: a review of clinical presentation, management and outcome in 45 cases","volume":"7","author":"Sibal","year":"2004","unstructured":"6. Sibal L, Ball SG, Connolly V, James RA, Kane P, Kelly WF, et al. Pituitary apoplexy: a review of clinical presentation, management and outcome in 45 cases. Pituitary. 2004;7(3):157-63.","journal-title":"Pituitary"},{"issue":"11","key":"key20210511112242_B7","doi-asserted-by":"crossref","first-page":"5649","DOI":"10.1210\/jc.2004-0884","article-title":"Extreme elevation of intrasellar pressure in patients with pituitary tumor apoplexy: relation to pituitary function","volume":"89","author":"Zayour","year":"2004","unstructured":"7. Zayour DH, Selman WR, Arafah BM. Extreme elevation of intrasellar pressure in patients with pituitary tumor apoplexy: relation to pituitary function. J Clin Endocrinol Metab. 2004;89(11):5649-54.","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"key20210511112242_B8","first-page":"602","article-title":"A retrospective analysis of pituitary apoplexy","volume":"33","author":"Bills","year":"1993","unstructured":"8. Bills DC, Meyer FB, Laws ER Jr, Davis DH, Ebersold MJ, Scheithauer BW, et al. A retrospective analysis of pituitary apoplexy. Neurosurgery. 1993;33(4):602-8; discussion 8-9.","journal-title":"Neurosurgery"},{"issue":"1","key":"key20210511112242_B9","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1530\/EJE-10-0651","article-title":"Pituitary apoplexy: re-evaluation of risk factors for bleeding into pituitary adenomas and impact on outcome","volume":"164","author":"M\u00f6ller-Goede","year":"2011","unstructured":"9. M\u00f6ller-Goede DL, Brandle M, Landau K, Bernays RL, Schmid C. Pituitary apoplexy: re-evaluation of risk factors for bleeding into pituitary adenomas and impact on outcome. Eur J Endocrinol. 2011;164(1):37-43.","journal-title":"Eur J Endocrinol"},{"issue":"5","key":"key20210511112242_B10","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1007\/s00701-009-0595-8","article-title":"Pituitary apoplexy: an overview of 186 cases published during the last century","volume":"152","author":"Turgut","year":"2010","unstructured":"10. Turgut M, Ozsunar Y, Ba\u015fak S, G\u00fcney E, Kir E, Meteo\u011flu I. Pituitary apoplexy: an overview of 186 cases published during the last century. Acta Neurochir (Wien). 2010;152(5):749-61.","journal-title":"Acta Neurochir (Wien)"},{"issue":"2","key":"key20210511112242_B11","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1007\/s11102-018-0870-x","article-title":"Apoplexy in nonfunctioning pituitary adenomas","volume":"21","author":"Wildemberg","year":"2018","unstructured":"11. Wildemberg LE, Glezer A, Bronstein MD, Gadelha MR. Apoplexy in nonfunctioning pituitary adenomas. Pituitary. 2018;21(2):138-44.","journal-title":"Pituitary"},{"issue":"824","key":"key20210511112242_B12","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1136\/pgmj.70.824.444","article-title":"Pituitary apoplexy after stimulation tests","volume":"70","author":"Vassallo","year":"1994","unstructured":"12. Vassallo M, Rana Z, Allen S. Pituitary apoplexy after stimulation tests. Postgrad Med J. 1994;70(824):444-5.","journal-title":"Postgrad Med J"},{"issue":"4","key":"key20210511112242_B13","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1136\/jnnp.71.4.542","article-title":"Precipitating factors in pituitary apoplexy","volume":"71","author":"Biousse","year":"2001","unstructured":"13. Biousse V, Newman NJ, Oyesiku NM. Precipitating factors in pituitary apoplexy. J Neurol Neurosurg Psychiatry. 2001;71(4):542-5.","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"1","key":"key20210511112242_B14","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/0002-9343(77)90122-X","article-title":"Pituitary apoplexy. Association of degenerative change in pituitary ademona with radiotherapy and detection by cerebral computed tomography","volume":"63","author":"Weisberg","year":"1977","unstructured":"14. Weisberg LA. Pituitary apoplexy. Association of degenerative change in pituitary ademona with radiotherapy and detection by cerebral computed tomography. Am J Med. 1977;63(1):109-15.","journal-title":"Am J Med"},{"issue":"6","key":"key20210511112242_B15","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1007\/s13244-014-0362-0","article-title":"Pituitary apoplexy: an update on clinical and imaging features","volume":"5","author":"Boellis","year":"2014","unstructured":"15. Boellis A, di Napoli A, Romano A, Bozzao A. Pituitary apoplexy: an update on clinical and imaging features. Insights Imaging. 2014;5(6):753-62.","journal-title":"Insights Imaging"},{"issue":"6","key":"key20210511112242_B16","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1227\/00006123-199006000-00010","article-title":"Clinical versus subclinical pituitary apoplexy: presentation, surgical management, and outcome in 21 patients","volume":"26","author":"Onesti","year":"1990","unstructured":"16. Onesti ST, Wisniewski T, Post KD. Clinical versus subclinical pituitary apoplexy: presentation, surgical management, and outcome in 21 patients. Neurosurgery. 1990;26(6):980-6.","journal-title":"Neurosurgery"},{"issue":"3-4","key":"key20210511112242_B17","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1007\/BF02112028","article-title":"Pituitary apoplexy: endocrine, surgical and oncological emergency. Incidence, clinical course and treatment with reference to 799 cases of pituitary adenomas","volume":"120","author":"Bonicki","year":"1993","unstructured":"17. Bonicki W, Kasperlik-Zaluska A, Koszewski W, Zgliczy\u0144ski W, Wislawski J. Pituitary apoplexy: endocrine, surgical and oncological emergency. Incidence, clinical course and treatment with reference to 799 cases of pituitary adenomas. Acta Neurochir (Wien). 1993;120(3-4):118-22.","journal-title":"Acta Neurochir (Wien)"},{"issue":"6","key":"key20210511112242_B18","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1111\/j.1365-2265.2004.02162.x","article-title":"Acute management of pituitary apoplexy\u2013\u2013surgery or conservative management?","volume":"61","author":"Ayuk","year":"2004","unstructured":"18. Ayuk J, McGregor EJ, Mitchell RD, Gittoes NJ. Acute management of pituitary apoplexy\u2013\u2013surgery or conservative management? Clin Endocrinol (Oxf). 2004;61(6):747-52.","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"7","key":"key20210511112242_B19","first-page":"502","article-title":"A conservative management is preferable in milder forms of pituitary tumor apoplexy","volume":"34","author":"Leyer","year":"2011","unstructured":"19. Leyer C, Castinetti F, Morange I, Gueydan M, Oliver C, Conte-Devolx B, et al. A conservative management is preferable in milder forms of pituitary tumor apoplexy. J Endocrinol Invest. 2011;34(7):502-9.","journal-title":"J Endocrinol Invest"},{"issue":"8","key":"key20210511112242_B20","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1002\/humu.21292","article-title":"Characterization of aryl hydrocarbon receptor interacting protein (AIP) mutations in familial isolated pituitary adenoma families","volume":"31","author":"Igreja","year":"2010","unstructured":"20. Igreja S, Chahal HS, King P, Bolger GB, Srirangalingam U, Guasti L, et al. Characterization of aryl hydrocarbon receptor interacting protein (AIP) mutations in familial isolated pituitary adenoma families. Hum Mutat. 2010;31(8):950-60.","journal-title":"Hum Mutat"},{"issue":"9","key":"key20210511112242_B21","doi-asserted-by":"crossref","first-page":"E1242","DOI":"10.1210\/jc.2015-1869","article-title":"Landscape of Familial Isolated and Young-Onset Pituitary Adenomas: Prospective Diagnosis in AIP Mutation Carriers","volume":"100","author":"Hernandez-Ramirez","year":"2015","unstructured":"21. Hernandez-Ramirez LC, Gabrovska P, Denes J, Stals K, Trivellin G, Tilley D, et al. Landscape of Familial Isolated and Young-Onset Pituitary Adenomas: Prospective Diagnosis in AIP Mutation Carriers. J Clin Endocrinol Metab. 2015;100(9):E1242-54.","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"key20210511112242_B22","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1210\/er.2012-1013","article-title":"Familial isolated pituitary adenomas (FIPA) and the pituitary adenoma predisposition due to mutations in the aryl hydrocarbon receptor interacting protein (AIP) gene","volume":"34","author":"Beckers","year":"2013","unstructured":"22. Beckers A, Aaltonen LA, Daly AF, Karhu A. Familial isolated pituitary adenomas (FIPA) and the pituitary adenoma predisposition due to mutations in the aryl hydrocarbon receptor interacting protein (AIP) gene. Endocr Rev. 2013;34(2):239-77.","journal-title":"Endocr Rev"},{"issue":"7","key":"key20210511112242_B23","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/j.tem.2010.02.007","article-title":"Clinical, genetic and molecular characterization of patients with familial isolated pituitary adenomas (FIPA)","volume":"21","author":"Chahal","year":"2010","unstructured":"23. Chahal HS, Chapple JP, Frohman LA, Grossman AB, Korbonits M. Clinical, genetic and molecular characterization of patients with familial isolated pituitary adenomas (FIPA). Trends Endocrinol Metab. 2010;21(7):419-27.","journal-title":"Trends Endocrinol Metab"},{"issue":"6","key":"key20210511112242_B24","doi-asserted-by":"crossref","first-page":"2390","DOI":"10.1210\/jc.2007-2611","article-title":"The role of the aryl hydrocarbon receptor-interacting protein gene in familial and sporadic pituitary adenomas","volume":"93","author":"Leontiou","year":"2008","unstructured":"24. Leontiou CA, Gueorguiev M, van der Spuy J, Quinton R, Lolli F, Hassan S, et al. The role of the aryl hydrocarbon receptor-interacting protein gene in familial and sporadic pituitary adenomas. J Clin Endocrinol Metab. 2008;93(6):2390-401.","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"key20210511112242_B25","doi-asserted-by":"crossref","first-page":"L11","DOI":"10.1530\/ERC-13-0218","article-title":"Familial pituitary apoplexy as the only presentation of a novel AIP mutation","volume":"20","author":"Xekouki","year":"2013","unstructured":"25. Xekouki P, Mastroyiannis SA, Avgeropoulos D, de la Luz Sierra M, Trivellin G, Gourgari EA, et al. Familial pituitary apoplexy as the only presentation of a novel AIP mutation. Endocr Relat Cancer. 2013;20(5):L11-4.","journal-title":"Endocr Relat Cancer"},{"issue":"11","key":"key20210511112242_B26","doi-asserted-by":"crossref","first-page":"E373","DOI":"10.1210\/jc.2009-2556","article-title":"Clinical Characteristics and Therapeutic Responses in Patients with Germ-Line AI Mutations and Pituitary Adenomas: An International Collaborative Study","volume":"95","author":"Daly","year":"2010","unstructured":"26. Daly AF, Tichomirowa MA, Petrossians P, Heli\u00f6vaara E, Jaffrain-Rea ML, Barlier A, et al. Clinical Characteristics and Therapeutic Responses in Patients with Germ-Line AIP Mutations and Pituitary Adenomas: An International Collaborative Study. J Clin Endocrinol Metab. 2010;95(11):E373-E83.","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"key20210511112242_B27","doi-asserted-by":"crossref","first-page":"E663","DOI":"10.1210\/jc.2011-2291","article-title":"Germline AI mutations in apparently sporadic pituitary adenomas: prevalence in a prospective single-center cohort of 443 patients","volume":"97","author":"Cazabat","year":"2012","unstructured":"27. Cazabat L, Bouligand J, Salenave S, Bernier M, Gaillard S, Parker F, et al. Germline AIP mutations in apparently sporadic pituitary adenomas: prevalence in a prospective single-center cohort of 443 patients. J Clin Endocrinol Metab. 2012;97(4):E663-70.","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"key20210511112242_B28","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1530\/ERC-11-0059","article-title":"Hyperplasia-adenoma sequence in pituitary tumorigenesis related to aryl hydrocarbon receptor interacting protein gene mutation","volume":"18","author":"Villa","year":"2011","unstructured":"28. Villa C, Lagonigro MS, Magri F, Koziak M, Jaffrain-Rea ML, Brauner R, et al. Hyperplasia-adenoma sequence in pituitary tumorigenesis related to aryl hydrocarbon receptor interacting protein gene mutation. Endocr Relat Cancer. 2011;18(3):347-56.","journal-title":"Endocr Relat Cancer"},{"key":"key20210511112242_B29","first-page":"629","article-title":"Headache Classification Committee of the International Headache Society (IHS)","volume-title":"The International Classification of Headache Disorders","year":"2013","unstructured":"29. Headache Classification Committee of the International Headache Society (IHS). The International Classification of Headache Disorders, 3rd edition (beta version). Cephalalgia. 2013;33(9):629-808.","edition":"3rd edition"},{"issue":"3","key":"key20210511112242_B30","first-page":"803","article-title":"Intracranial hemorrhage: gradient-echo MR imaging at 1.5 T","volume":"168","author":"Atlas","year":"1988","unstructured":"30. Atlas SW, Mark AS, Grossman RI, Gomori JM. Intracranial hemorrhage: gradient-echo MR imaging at 1.5 T. Comparison with spin-echo imaging and clinical applications. Radiology. 1988;168(3):803-7.","journal-title":"Comparison with spin-echo imaging and clinical applications. Radiology"},{"key":"key20210511112242_B31","first-page":"989","article-title":"The volume of the sella turcica","volume":"87","author":"Di Chiro","year":"1962","unstructured":"31. Di Chiro G, Nelson KB. The volume of the sella turcica. Am J Roentgenol Radium Ther Nucl Med. 1962;87:989-1008.","journal-title":"Am J Roentgenol Radium Ther Nucl Med"},{"issue":"1","key":"key20210511112242_B32","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1148\/rg.261055045","article-title":"T1 signal hyperintensity in the sellar region: spectrum of findings","volume":"26","author":"Bonneville","year":"2006","unstructured":"32. Bonneville F, Cattin F, Marsot-Dupuch K, Dormont D, Bonneville JF, Chiras J. T1 signal hyperintensity in the sellar region: spectrum of findings. Radiographics. 2006;26(1):93-113.","journal-title":"Radiographics"},{"issue":"1","key":"key20210511112242_B33","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1530\/EJE-07-0181","article-title":"Germline inactivating mutations of the aryl hydrocarbon receptor-interacting protein gene in a large cohort of sporadic acromegaly: mutations are found in a subset of young patients with macroadenomas","volume":"157","author":"Cazabat","year":"2007","unstructured":"33. Cazabat L, Libe R, Perlemoine K, Rene-Corail F, Burnichon N, Gimenez-Roqueplo AP, et al. Germline inactivating mutations of the aryl hydrocarbon receptor-interacting protein gene in a large cohort of sporadic acromegaly: mutations are found in a subset of young patients with macroadenomas. Eur J Endocrinol. 2007;157(1):1-8.","journal-title":"Eur J Endocrinol"},{"issue":"7","key":"key20210511112242_B34","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1089\/gtmb.2014.0333","article-title":"Do the Aryl Hydrocarbon Receptor Interacting Protein Variants (Q228K and Q307R) Play a Role in Patients with Familial and Sporadic Hormone-Secreting Pituitary Adenomas?","volume":"19","author":"Yarman","year":"2015","unstructured":"34. Yarman S, Ogret YD, Oguz FS. Do the Aryl Hydrocarbon Receptor Interacting Protein Variants (Q228K and Q307R) Play a Role in Patients with Familial and Sporadic Hormone-Secreting Pituitary Adenomas? Genet Test Mol Biomarkers. 2015;19(7):394-8.","journal-title":"Genet Test Mol Biomarkers"},{"key":"key20210511112242_B35","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.wneu.2017.08.131","article-title":"Endoscopic Endonasal Surgery for Treatment of Pituitary Apoplexy: 16 Years of Experience in a Specialized Pituitary Center","volume":"108","author":"Gondim","year":"2017","unstructured":"35. Gondim JA, de Albuquerque LAF, Almeida JP, Bulcao T, Gomes E, Schops M, et al. Endoscopic Endonasal Surgery for Treatment of Pituitary Apoplexy: 16 Years of Experience in a Specialized Pituitary Center. World Neurosurg. 2017;108:137-42.","journal-title":"World Neurosurg"},{"key":"key20210511112242_B36","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.clineuro.2017.10.006","article-title":"Pituitary apoplexy \u2013 A single center retrospective study from the neurosurgical perspective and review of the literature","volume":"163","author":"Grzywotz","year":"2017","unstructured":"36. Grzywotz A, Kleist B, Moller LC, Hans VH, Goricke S, Sure U, et al. Pituitary apoplexy \u2013 A single center retrospective study from the neurosurgical perspective and review of the literature. Clin Neurol Neurosurg. 2017;163:39-45.","journal-title":"Clin Neurol Neurosurg"},{"issue":"3","key":"key20210511112242_B37","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1111\/cen.13075","article-title":"Pituitary apoplexy \u2013 bespoke patient management allows good clinical outcome","volume":"85","author":"Giritharan","year":"2016","unstructured":"37. Giritharan S, Gnanalingham K, Kearney T. Pituitary apoplexy \u2013 bespoke patient management allows good clinical outcome. Clin Endocrinol (Oxf). 2016;85(3):415-22.","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"6","key":"key20210511112242_B38","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.3171\/2014.10.JNS141204","article-title":"Management and outcomes of pituitary apoplexy","volume":"122","author":"Singh","year":"2015","unstructured":"38. Singh TD, Valizadeh N, Meyer FB, Atkinson JL, Erickson D, Rabinstein AA. Management and outcomes of pituitary apoplexy. J Neurosurg. 2015;122(6):1450-7.","journal-title":"J Neurosurg"},{"issue":"5","key":"key20210511112242_B39","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1016\/j.wneu.2014.06.005","article-title":"Pituitary apoplexy: large surgical series with grading system","volume":"82","author":"Jho","year":"2014","unstructured":"39. Jho DH, Biller BM, Agarwalla PK, Swearingen B. Pituitary apoplexy: large surgical series with grading system. World Neurosurg. 2014;82(5):781-90.","journal-title":"World Neurosurg"},{"issue":"3","key":"key20210511112242_B40","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1111\/cen.12307","article-title":"Presentation, management and outcomes in acute pituitary apoplexy: a large single-centre experience from the United Kingdom","volume":"80","author":"Bujawansa","year":"2014","unstructured":"40. Bujawansa S, Thondam SK, Steele C, Cuthbertson DJ, Gilkes CE, Noonan C, et al. Presentation, management and outcomes in acute pituitary apoplexy: a large single-centre experience from the United Kingdom. Clin Endocrinol (Oxf). 2014;80(3):419-24.","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"4","key":"key20210511112242_B41","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1111\/j.1365-2265.2011.04068.x","article-title":"Pituitary apoplexy in non-functioning pituitary adenomas: long term follow up is important because of significant numbers of tumour recurrences","volume":"75","author":"Pal","year":"2011","unstructured":"41. Pal A, Capatina C, Tenreiro AP, Guardiola PD, Byrne JV, Cudlip S, et al. Pituitary apoplexy in non-functioning pituitary adenomas: long term follow up is important because of significant numbers of tumour recurrences. Clin Endocrinol (Oxf). 2011;75(4):501-4.","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"3","key":"key20210511112242_B42","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1097\/01.md.0000164205.77287.9e","article-title":"Apoplexy in pituitary macroadenoma: eight patients presenting in 12 months","volume":"84","author":"Elsasser Imboden","year":"2005","unstructured":"42. Elsasser Imboden PN, De Tribolet N, Lobrinus A, Gaillard RC, Portmann L, Pralong F, et al. Apoplexy in pituitary macroadenoma: eight patients presenting in 12 months. Medicine. 2005;84(3):188-96.","journal-title":"Medicine"},{"issue":"1","key":"key20210511112242_B43","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1227\/01.NEU.0000144840.55247.38","article-title":"Pituitary apoplexy","volume":"56","author":"Semple","year":"2005","unstructured":"43. Semple PL, Webb MK, de Villiers JC, Laws ER, Jr. Pituitary apoplexy. Neurosurgery. 2005;56(1):65-72; discussion -3.","journal-title":"Neurosurgery"},{"issue":"1","key":"key20210511112242_B44","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.clineuro.2006.01.006","article-title":"Classical pituitary tumour apoplexy: clinical features, management and outcomes in a series of 24 patients","volume":"109","author":"Dubuisson","year":"2007","unstructured":"44. Dubuisson AS, Beckers A, Stevenaert A. Classical pituitary tumour apoplexy: clinical features, management and outcomes in a series of 24 patients. Clin Neurol Neurosurg. 2007;109(1):63-70.","journal-title":"Clin Neurol Neurosurg"},{"issue":"6","key":"key20210511112242_B45","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1210\/er.2015-1042","article-title":"Pituitary Apoplexy","volume":"36","author":"Briet","year":"2015","unstructured":"45. Briet C, Salenave S, Bonneville JF, Laws ER, Chanson P. Pituitary Apoplexy. Endocr Rev. 2015;36(6):622-45.","journal-title":"Endocr Rev"},{"issue":"2B","key":"key20210511112242_B46","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1590\/S0004-282X2008000300028","article-title":"Transient central diabetes insipidus followed by pituitary apoplexy treated in a conservative way","volume":"66","author":"Silva","year":"2008","unstructured":"46. Silva CM, Lima GA, Machado EO, Van Haute FR, Gadelha MR. Transient central diabetes insipidus followed by pituitary apoplexy treated in a conservative way. Arq Neuro-Psiquiatr. 2008;66(2B):415-7.","journal-title":"Arq Neuro-Psiquiatr"},{"issue":"5","key":"key20210511112242_B47","doi-asserted-by":"crossref","first-page":"e97","DOI":"10.4158\/EP11341.CR","article-title":"Association of dengue hemorrhagic fever with multiple risk factors for pituitary apoplexy","volume":"18","author":"Wildemberg","year":"2012","unstructured":"47. Wildemberg LE, Neto LV, Niemeyer P, Gasparetto EL, Chimelli L, Gadelha MR. Association of dengue hemorrhagic fever with multiple risk factors for pituitary apoplexy. Endocr Pract. 2012;18(5):e97-e101.","journal-title":"Endocr Pract"},{"issue":"3","key":"key20210511112242_B48","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1007\/s11102-007-0046-6","article-title":"Pituitary apoplexy during treatment of cystic macroprolactinomas with cabergoline","volume":"11","author":"Balarini Lima","year":"2008","unstructured":"48. Balarini Lima GA, Machado Ede O, Dos Santos Silva CM, Filho PN, Gadelha MR. Pituitary apoplexy during treatment of cystic macroprolactinomas with cabergoline. Pituitary. 2008;11(3):287-92.","journal-title":"Pituitary"},{"issue":"1","key":"key20210511112242_B49","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1148\/radiology.189.1.8372185","article-title":"MR appearance of hemorrhage in the brain","volume":"189","author":"Bradley","year":"1993","unstructured":"49. Bradley WG Jr. MR appearance of hemorrhage in the brain. Radiology. 1993;189(1):15-26.","journal-title":"Radiology"},{"issue":"5","key":"key20210511112242_B50","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1007\/s003300050767","article-title":"The various MRI patterns of pituitary apoplexy","volume":"9","author":"Piotin","year":"1999","unstructured":"50. Piotin M, Tampieri D, Rufenacht DA, Mohr G, Garant M, Del Carpio R, et al. The various MRI patterns of pituitary apoplexy. Eur Radiol. 1999;9(5):918-23.","journal-title":"Eur Radiol"},{"issue":"5","key":"key20210511112242_B51","doi-asserted-by":"crossref","first-page":"897","DOI":"10.3171\/jns.2001.95.5.0897","article-title":"Thickening of sphenoid sinus mucosa during the acute stage of pituitary apoplexy","volume":"95","author":"Arita","year":"2001","unstructured":"51. Arita K, Kurisu K, Tominaga A, Sugiyama K, Ikawa F, Yoshioka H, et al. Thickening of sphenoid sinus mucosa during the acute stage of pituitary apoplexy. J Neurosurg. 2001;95(5):897-901.","journal-title":"J Neurosurg"},{"issue":"4","key":"key20210511112242_B52","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1007\/s11102-017-0804-z","article-title":"Sphenoid sinus mucosal thickening in the acute phase of pituitary apoplexy","volume":"20","author":"Waqar","year":"2017","unstructured":"52. Waqar M, McCreary R, Kearney T, Karabatsou K, Gnanalingham KK. Sphenoid sinus mucosal thickening in the acute phase of pituitary apoplexy. Pituitary. 2017;20(4):441-9.","journal-title":"Pituitary"},{"issue":"6","key":"key20210511112242_B53","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1080\/02688690601046678","article-title":"Pituitary apoplexy: retrospective review of 30 patients\u2013\u2013is surgical intervention always necessary?","volume":"20","author":"Gruber","year":"2006","unstructured":"53. Gruber A, Clayton J, Kumar S, Robertson I, Howlett TA, Mansell P. Pituitary apoplexy: retrospective review of 30 patients\u2013\u2013is surgical intervention always necessary? Br J Neurosurg. 2006;20(6):379-85.","journal-title":"Br J Neurosurg"},{"issue":"7","key":"key20210511112242_B54","first-page":"2190","article-title":"Conservative management of pituitary apoplexy: a prospective study","volume":"80","author":"Maccagnan","year":"1995","unstructured":"54. Maccagnan P, Macedo CL, Kayath MJ, Nogueira RG, Abucham J. Conservative management of pituitary apoplexy: a prospective study. J Clin Endocrinol Metab. 1995;80(7):2190-7.","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"key20210511112242_B55","doi-asserted-by":"crossref","DOI":"10.3171\/foc.2004.16.4.7","article-title":"Pituitary tumor apoplexy: characteristics, treatment, and outcomes","volume":"16","author":"Verrees","year":"2004","unstructured":"55. Verrees M, Arafah BM, Selman WR. Pituitary tumor apoplexy: characteristics, treatment, and outcomes. Neurosurg Focus. 2004;16(4):E6.","journal-title":"Neurosurg Focus"},{"issue":"5","key":"key20210511112242_B56","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1227\/00006123-199111000-00005","article-title":"Pituitary apoplexy and its effect on vision","volume":"29","author":"McFadzean","year":"1991","unstructured":"56. McFadzean RM, Doyle D, Rampling R, Teasdale E, Teasdale G. Pituitary apoplexy and its effect on vision. Neurosurgery. 1991;29(5):669-75.","journal-title":"Neurosurgery"},{"issue":"5","key":"key20210511112242_B57","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1590\/S0004-27302011000500008","article-title":"Conservative management of pituitary tumor apoplexy","volume":"55","author":"Santos","year":"2011","unstructured":"57. Santos AB, Franca MM, Hirosawa RM, Marivo M, Zanini MA, Nunes VS. Conservative management of pituitary tumor apoplexy. Arq Bras Endocrinol Metab. 2011;55(5):345-8.","journal-title":"Arq Bras Endocrinol Metab"},{"issue":"5","key":"key20210511112242_B58","doi-asserted-by":"crossref","first-page":"1891","DOI":"10.1210\/jc.2006-2513","article-title":"Aryl Hydrocarbon Receptor-Interacting Protein Gene Mutations in Familial Isolated Pituitary Adenomas: Analysis in 73 Families","volume":"92","author":"Daly","year":"2007","unstructured":"58. Daly AF, Vanbellinghen JF, Khoo SK, Jaffrain-Rea ML, Naves LA, Guitelman MA, et al. Aryl Hydrocarbon Receptor-Interacting Protein Gene Mutations in Familial Isolated Pituitary Adenomas: Analysis in 73 Families. J Clin Endocrinol Metab. 2007;92(5):1891-6.","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"key20210511112242_B59","doi-asserted-by":"crossref","first-page":"431","DOI":"10.2133\/dmpk.DMPK-11-SC-013","article-title":"An Evaluation of Single Nucleotide Polymorphisms in the Human Aryl Hydrocarbon Receptor-Interacting Protein (AIP) Gene","volume":"26","author":"Rowlands","year":"2011","unstructured":"59. Rowlands C, Urban J, Wikoff D, Budinsky R. An Evaluation of Single Nucleotide Polymorphisms in the Human Aryl Hydrocarbon Receptor-Interacting Protein (AIP) Gene. Drug Metab Pharmacokinet. 2011;26(4):431-9.","journal-title":"Drug Metab Pharmacokinet"},{"issue":"4","key":"key20210511112242_B60","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1136\/jmedgenet-2017-104957","article-title":"Risk category system to identify pituitary adenoma patients with AIP mutations","volume":"55","author":"Caimari","year":"2018","unstructured":"60. Caimari F, Hern\u00e1ndez-Ram\u00edrez LC, Dang MN, Gabrovska P, Iacovazzo D, Stals K, et al. Risk category system to identify pituitary adenoma patients with AIP mutations. J Med Genet. 2018;55(4):254-60.","journal-title":"J Med Genet"}],"container-title":["Archives of Endocrinology and Metabolism"],"original-title":[],"language":"en","deposited":{"date-parts":[[2021,5,11]],"date-time":"2021-05-11T15:40:59Z","timestamp":1620747659000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.scielo.br\/scielo.php?script=sci_arttext&pid=S2359-39972021005006201&lng=en&nrm=iso&tlng=en"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4,27]]},"references-count":60,"alternative-id":["10.20945\/2359-3997000000358"],"URL":"https:\/\/doi.org\/10.20945\/2359-3997000000358","relation":{},"ISSN":["2359-3997","2359-4292"],"issn-type":[{"type":"print","value":"2359-3997"},{"type":"electronic","value":"2359-4292"}],"subject":[],"published":{"date-parts":[[2021,4,27]]}}}